Using Scaffold Hopping to Search Nearby Chemical Space
How Can Computational Chemistry Help Find New Drugs from Old? In this series of blogs, Dr Robert Scoffin, CEO of Cresset, explores how computational chemistry is being applied to the field of...
View ArticleConsulting services as try-before-you-buy option
Customers often use Cresset’s consulting services to evaluate our techniques before they buy the software As CEO of a software and services company, I am sometimes asked whether Cresset is a software...
View ArticleUsability and scientific usefulness – a difficult act to balance?
At Cresset we are proud of our combination of intuitive user interfaces and powerful underlying science. We take the time and thought to design our software so that it is as easy to use as possible. We...
View ArticleEnd of Year Message from CEO
I am writing this message having recently returned from a trade mission to China where I was inspired by the phenomenal economic growth and dynamic approaches to doing business in a rapidly expanding...
View ArticleRapidly identifying profitable new indications for existing drugs
日本語 Profitable reprofiling opportunities are often created by the publication of new biological targets. When new targets are identified, Blaze can be used to make a rapid assessment of whether any...
View ArticleFrom virtual screening to real compounds
Managing the procurement process to deliver plated compounds to your door Cresset consulting services runs computational experiments to help you understand your chemistry better. The usual result from...
View ArticleCresset adds to scientific and commercial team in Cambridge
In response to our continued business growth we are delighted to announce that Paolo Tosco has joined us as a Computational Chemistry Developer and Ritesh Chauhan has joined us as Account Manager for...
View ArticleEnd of year message from Dr Robert Scoffin, CEO of Cresset
As we near the end of the year it is great to look back at how we have helped our customers deliver concrete results in 2014. Commercial R&D is highly competitive and customer confidentiality is of...
View ArticleCEO end of year message 2015
As we head towards the end of the year, I reflect that 2015 has seen many exciting and challenging changes. As a business we have developed and made progress in all directions. New worldwide relations...
View ArticleUser Group Meetings 2016 review
The Cresset 2016 North American and European User Group Meetings combined presentations and workshops in Cambridge, MA and UK respectively. A large and diverse group of scientists gathered to share...
View ArticleCEO end of year message 2016
2016 has been a year of exciting developments for Cresset. We have been working hard on developing an outstanding new software tool for discovery, we have expanded our services offering and we have...
View ArticleLink prescriptions to medical conditions to pave the way for more repurposed...
By David Cavalla, Numedicus Limited. Repurposed drugs are often subject to off-label generic substitution, making them an unattractive development route for some pharmaceutical companies....
View ArticleCEO end of year message 2017
Dr Robert Scoffin, CEO, Cresset As 2017 draws to a close I’d like to take the opportunity to say a huge thank you to all of our customers, partners and staff for your support, collaboration and hard...
View ArticleCEO end of year message 2018
Dr Robert Scoffin, CEO As we near the end of the year I’ve been reflecting on the progress we’ve made. During 2018 we’ve seen major developments in Cresset Discovery Services, in software development,...
View ArticleThe virtuous circle: Cultivating closer ties between academia and industry
Academia and industry always have a lot to gain from cultivating close ties with each other. As with any relationship, getting the balance right between give and take starts with a generous attitude...
View Article
More Pages to Explore .....